Skip to content
Screener

Sabra Healthcare SBRA Q4 2025 Annual earnings

Reported February 12, 2026 · After market close

Revenue$211.9MBeat by $13.9M
EPS$0.38Beat by $0.21
Revenue estimate$198.0M
EPS estimate$0.17

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$234.0M
EPS estimate$0.17

Financials

Q4 2025

Income statement

See full
Revenue$211.9M+16.2%
Net income$27.2M-41.7%
EPS (diluted)$0.11-45.0%

Balance sheet

See full
Cash & equivalents$71.5M+18.3%
Total debt$7.4M-10.8%
Total equity$2.8B+2.9%
Total assets$5.5B+3.6%

Cash flow

See full
Operating cash flow$87.4M+9.3%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$4.72B+15.3%
Enterprise value$4.66B+15.2%
P/E30.3×-2.0×
P/S6.1×+0.3×

Profitability

See full
Net margin20.1%+2.1pp

Returns & leverage

See full
Return on equity5.6%+1.0pp
Debt / equity0×0.0×

FAQ

When did Sabra Healthcare report Q4 2025 earnings?
Sabra Healthcare (SBRA) reported Q4 2025 earnings on February 12, 2026 after market close.
What were Sabra Healthcare's Q4 2025 revenue and EPS?
Sabra Healthcare reported revenue of $211.9M and eps of $0.38 for Q4 2025.
Did Sabra Healthcare beat estimates in Q4 2025?
Revenue beat the consensus estimate of $198.0M by $13.9M. EPS beat the consensus estimate of $0.17 by $0.21.
How did Sabra Healthcare's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 16.2% from $182.3M a year earlier and eps grew 5.6% from $0.36.
Where can I find Sabra Healthcare's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001492298-26-000007) and the 10-K periodic report (0001492298-26-000008) directly on SEC EDGAR. The filing index links above go to sec.gov.